Company:  NEOGENOMICS INC (NEO)
Form Type:  4
Filing Date:  11/8/2019 
CIK:  0001077183 
Address:  12701 COMMONWEALTH DRIVE
SUITE 9
 
City, State, Zip:  FORT MYERS, Florida 33913 
Telephone:  (941) 923-1949 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$23.77  
Change: 
0.29 (1.24%)  
Trade Time: 
12:13 PM EST  
Market Cap: 
$2.48B
Trade NEO now with

© 2019  
Description of Business
NeoGenomics, Inc., a Nevada corporation (referred to individually as the "Parent Company" or collectively with its subsidiaries as "NeoGenomics", "we", "us", "our" or the "Company" in this Annual Report) is the registrant for SEC reporting purposes. Our common stock is listed on the NASDAQ Capital Market under the symbol "NEO". Overview We operate a network of cancer-focused genetic testing laboratories in the United States as well as a laboratories in Switzerland and Singapore. Our mission is to improve patient care through exceptional genetic and molecular testing services. Our vision is to become the World's leading cancer testing and information company by delivering uncompromising quality, exceptional service and innovative solutions. As of December 31, 2018, the Company has laboratory locations in Ft.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES